Buprenorphine Hydrochloride Injection recall — Class II (D-0564-2024) · pharmaranks
Class IIOngoing
Buprenorphine Hydrochloride Injection recall
FDA recall D-0564-2024 · initiated May 20, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Details
Product
Buprenorphine Hydrochloride Injection, 0.3 mg base/mL, 1 mL Single-dose Carpuject, Sterile Cartridge Unit with Luer Lock, For Intramuscular or Intravenous Use, Rx Only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC: 0409-2012-03
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.